Healthline — Latest Headlines

FDA Approves ‘First-in-Class’ NDSRI for ADHD in Adults and Children

SIMTRIYO is a newly approved central nervous system medication to help treat ADHD in children and adults. Tom Werner/DigitalVision/Getty Images Federal regulators have approved a new medication to

Healthline· just now

GLP-1s Like Ozempic, Wegovy Can Help Maintain Lower Calorie Intake for Over 1 Year

Health

Healthline· just now

Viagra’s Active Ingredient May Also Help Stop Cancer From Spreading

Healthline· just now

Higher Body Fat Linked to Low Sperm Count, Testosterone. Here's Why

Healthline· just now

Early Menopause Linked to High Blood Pressure. How to Lower Your Risk

About this feed

The latest Healthline headlines, updated throughout the day. Read Healthline alongside your other health sources on Daily Huber.

More health news →

Daily Huber

FDA Approves ‘First-in-Class’ NDSRI for ADHD in Adults and Children

Trending Topics

Why You Don't Need to Avoid Fruits, Veggies During the Cyclospora Outbreak

Tylenol with Naproxen: FDA Approves Fast-Acting Non-Opioid for Pain Relief

‘Menopause Cocktail’: Can Allergy, Acid Reflux Meds Help Alleviate Symptoms?

GLP-1s Like Ozempic, Wegovy Can Help Maintain Lower Calorie Intake for Over 1 Year

Health

Viagra’s Active Ingredient May Also Help Stop Cancer From Spreading

Higher Body Fat Linked to Low Sperm Count, Testosterone. Here's Why

Early Menopause Linked to High Blood Pressure. How to Lower Your Risk

About this feed

Related sources